Table 2 Hematologic characteristics and iron status biomarkers in normal weight (NW), overweight (OW), and obese (OB) Swiss women (n = 62)
NW | OW | OB | OW/OB | |
|---|---|---|---|---|
n | 24 | 19 | 19 | 38 |
Blood volume (mL/kg)b | 74.9 ± 5.8d,e,f | 64.3 ± 5.3e | 59.4 ± 7.1 | 61.8 ± 6.7 |
Blood volume (L)b | 4.59 ± 0.46d,e,f | 5.10 ± 0.58 | 5.33 ± 1.01 | 5.21 ± 0.82 |
Plasma volume (mL/kg)b | 46.6 ± 4.8d,e,f | 40.1 ± 4.1 | 36.9 ± 4.9 | 38.5 ± 4.7 |
Plasma volume (L)b | 2.86 ± 0.30d,e,f | 3.17 ± 0.40 | 3.31 ± 0.66 | 3.24 ± 0.54 |
RBC (mL/kg)b | 28.2 ± 2.1d,e,f | 24.3 ± 2.6 | 22.4 ± 2.8 | 23.4 ± 2.8 |
RBC volume (L)b | 1.74 ± 0.22d,e,f | 1.93 ± 0.26 | 2.02 ± 0.39 | 1.97 ± 0.33 |
Hb (g/dL)b | 13.5 ± 0.9 | 13.7 ± 1.2 | 13.7 ± 1.0 | 13.7 ± 1.1 |
Hb mass (g/kg)b | 9.2 ± 0.7d,e,f | 7.9 ± 0.8 | 7.3 ± 0.9 | 7.6 ± 0.9 |
Total Hb (g)b | 566 ± 71d,e,f | 627 ± 85 | 656 ± 126 | 641 ± 107 |
Serum iron (μg/mL)b | 1.06 ± 0.44e | 1.01 ± 0.35 | 0.75 ± 0.27 | 0.89 ± 0.33 |
Total serum iron (mg)b | 3.02 ± 1.28e | 3.14 ± 0.98e | 2.50 ± 1.00 | 2.82 ± 1.03 |
TIBC (μg/mL)b | 3.68 ± 0.66e | 3.62 ± 0.66 | 3.17 ± 0.66 | 3.39 ± 0.69 |
Total TIBC (mg)b | 10.5 ± 2.28 | 11.6 ± 3.00 | 10.3 ± 2.18 | 10.9 ± 2.66 |
Transferrin saturation (%) | 29.8 ± 13.4 | 29.1 ± 12.1 | 24.6 ± 8.66 | 26.8 ± 10.6 |
sTfR (mg/L)c | 6.61 (5.86, 7.45) | 6.69 (5.82, 7.68) | 7.00 (5.90, 8.30) | 6.84 (6.16, 7.59) |
Total sTfR (mg)c | 18.8 (15.0, 21.5)f | 21.1 (16.1, 27.4) | 22.8 (15.6, 33.0) | 21.9 (16.6, 28.7) |
SF (µg/L)c | 50.6 (40.2, 63.4) | 59.9 (41.3, 86.8) | 62.8 (45.4, 86.9) | 61.35 (48.5, 77.6) |
Total SF (mg)c | 0.14 (0.10, 0.18)f | 0.19 (0.11, 0.31) | 0.20 (0.12, 0.35) | 0.20 (0.13, 0.29) |
Body iron (mg/kg)b | 5.64 ± 2.70 | 5.92 ± 3.31 | 5.46 ± 3.10 | 5.70 ± 3.17 |
Serum hepcidin (ng/mL)b | 9.20 ± 6.44 | 11.36 ± 6.73 | 12.48 ± 5.90 | 11.92 ± 6.3 |
Total hepcidin (µg)b | 25.5 ± 17.6 | 35.4 ± 21.1 | 41.2 ± 21.5 | 38.3 ± 21.2 |